---
title: "Indaptus Therapeutics (INDP.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/INDP.US/norm.md"
symbol: "INDP.US"
name: "Indaptus Therapeutics"
parent: "https://longbridge.com/en/quote/INDP.US.md"
datetime: "2026-05-20T14:41:25.093Z"
locales:
  - [en](https://longbridge.com/en/quote/INDP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INDP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INDP.US/norm.md)
---

# Indaptus Therapeutics (INDP.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2319 | -4.51 | -2.98 | -9.10 | -9.00 |
| ROE | -463.12% | -837.70% | -811.66% | -3713.81% | -537.61% |
| Revenue | - | - | - | - | - |
| Net income | -2.54M | -8.11M | -2.98M | -5.23M | -4.53M |
| Operating income | -2.57M | -8.16M | -2.65M | -4.46M | -4.57M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.18M | 9.31M | 6.84M | 6.84M | 5.41M |
| Leverage | 1.75 | 2.95 | 1.49 | -4.09 | 1.93 |
| BVPS | 0.0110 | 1.45 | 2.81 | -2.77 | 4.89 |
| Turnover | - | - | - | - | - |
| Cash & STI | 1.50M | 8.51M | 5.83M | 6.16M | 3.89M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | 8487.00 | 33577.00 | 58119.00 |
| Net debt | -1.50M | -8.51M | -5.82M | 379175.00 | -3.83M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -7.01M | -3.19M | -2.57M | -4.02M | -5.05M |
| Investing CF | - | - | - | - | - |
| Financing CF | - | 5.87M | 2.24M | 6.28M | 3.15M |
| Free CF | -6.30M | -567751.00 | -1.61M | -2.37M | -3.61M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | 0.0000 | 0.0000 | 5.71M | - |
| CapEx | - | - | - | - | - |